Sensus Healthcare (SRTS) Non-Current Deferred Tax Liability (2020 - 2025)
Sensus Healthcare's (SRTS) quarterly Non-Current Deferred Tax Liability came in at $12000.0 in Q4 2025, down 42.86% year-on-year from $21000.0 in Q4 2024, and down 42.86% quarter-over-quarter from $21000.0 in Q4 2024.
Sensus Healthcare (SRTS) Non-Current Deferred Tax Liability (2020 - 2025) Analysis & Trends
Sensus Healthcare's Non-Current Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $12000.0 for Q4 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability fell 42.86% year-over-year to $12000.0 in Q4 2025; TTM through Dec 2025 was $12000.0, a 42.86% decrease from a year earlier, with the FY2025 full-year figure at $12000.0, down 42.86% from the prior year.
- Non-Current Deferred Tax Liability declined to $12000.0 in Q4 2025 per SRTS's latest filing, from $21000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $1.7 million in Q4 2022 and bottomed at $12000.0 in Q4 2025.
- The 5-year median for Non-Current Deferred Tax Liability is $139000.0 (2021), against an average of $294375.0.
- Across the five-year window, Non-Current Deferred Tax Liability soared 1315.7% in 2022 and sank 99.01% in 2023, its largest moves.
- Year by year, Non-Current Deferred Tax Liability stood at $121000.0 in 2021, then surged by 1315.7% to $1.7 million in 2022, then sank by 99.01% to $17000.0 in 2023, then increased by 23.53% to $21000.0 in 2024, then tumbled by 42.86% to $12000.0 in 2025.
- Per Business Quant, the three latest SRTS Non-Current Deferred Tax Liability figures stand at $12000.0 (Q4 2025), $21000.0 (Q4 2024), and $17000.0 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Sensus Healthcare | 50.14 Mn | 31.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2022 | 1.71 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 157,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Jun 30, 2022 | 157,000.00 |
| Jun 30, 2022 | 157,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Dec 31, 2021 | 121,000.00 |
| Dec 31, 2020 | 528,300.00 |
| Dec 31, 2020 | 528,300.00 |
| Sep 30, 2020 | 528,300.00 |
| Sep 30, 2020 | 528,300.00 |